Early effects of treatment with nebivolol and quinapril on endothelial function in patients with hypertension

Endothelium: Journal of Endothelial Cell Research

Volumn 15, Issue 3, 2008, Pages 149-155

  Korkmaz, Hasan ^a   Karaca, Ilgin ^b   Koc, Mustafa ^b   Onalan, Orhan ^c   Yilmaz, Mucahit ^b   Bilen, Mehmet Nail ^b  

^a Elaziǧ Education and Research Hospital ^*  (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Endothelial Disfunction; FMD; Hypertension; Nebivolol; Quinapril; Resistive Index

Indexed keywords

ISOSORBIDE DINITRATE; NEBIVOLOL; QUINAPRIL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BRACHIAL ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART RATE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; VASODILATATION;

ADULT; ANTIHYPERTENSIVE AGENTS; BENZOPYRANS; BRACHIAL ARTERY; DIASTOLE; ENDOTHELIUM, VASCULAR; ETHANOLAMINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; RISK FACTORS; TETRAHYDROISOQUINOLINES; TIME FACTORS; TREATMENT OUTCOME; VASODILATION;

EID: 45949084608     PISSN: 10623329     EISSN: 10292373     Source Type: Journal    
DOI: 10.1080/10623320802125565     Document Type: Article

References (23)

1. Brixius, K., Bundkirchen, A., Bolck, B., Mehlhorn, U. and Schwinger, R. H. (2001) Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium. British Journal of Pharmacology, 133, pp. 1330-1338.
2. Bugiardini, R., Manfrini, O., Pizzi, C., Fontana, F. and Morgagni, G. (2004) Endothelial function predicts future development of coronary artery disease: A study of women with chest pain and normal coronary angiograms. Circulation, 109, pp. 2518-2523.
3. Cockcroft, J. R., Chowienczyk, P. J., Brett, S. E., Chen, C. P., Dupont, A. G. Van Nueten, L. et al. (1995) Nebivolol vasodilates human forearm vasculature: Evidence for an l-arginine/NO-dependent mechanism. Journal of Pharmacology and Experimental Therapeutics, 274, pp. 1067-1071.
4. Corretti, M. C., Anderson, T. J., Benjamin, E. J., Celermajer, D., Charbonneau, F. Creager, M. A. et al. (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. Journal of the American College of Cardiology, 39, pp. 257-265.
5. Dawes, M., Brett, S. E., Chowienczyk, P. J., Mant, T. G. and Ritter, J. M. (1999) The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension. British Journal of Clinical Pharmacology, 48, pp. 460-463.
6. Fratta Pasini, A., Garbin, U., Nava, M. C., Stranieri, C., Davoli, A. and Sawamuram, T. (2005) Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation. Journal of Hypertension, 23, pp. 589-596.
7. Frauchiger, B., Schmid, H. P., Roedel, C., Moosmann, P. and Staub, D. (2001) Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke, 32, pp. 836-841.
8. Gao, Y. S., Nagao, T., Bond, R. A., Janssens, W. J. and Vanhoutte, P. M. (1991) Nebivolol induces endothelium-dependent relaxations of canine coronary arteries. Journal of Cardiovascular Pharmacology, 17, pp. 964-969.
9. Glagov, S., Weisenberg, E., Zarins, C. K., Stankunavicius, R. and Kolettis, G. J. (1987) Compensatory enlargement of human atherosclerotic coronary arteries. New England Journal of Medicine, 316, pp. 1371-1375.
10. Halcox, J. P., Schenke, W. H. Zalos, G. et al. (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation, 106, pp. 653-658.
11. Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T. and Munzel, T. (2001) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation, 104, pp. 2673-2678.
12. Intengan, H. D. and Schiffrin, E. L. (2000) Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries. Journal of Cardiovascular Pharmacology, 35, pp. 763-768.
13. Luckhoff, A., Pohl, U., Mulsch, A. and Busse, R. (1988) Differential role of extra-and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells. British Journal of Pharmacology, 95, pp. 189-196.
14. Mancini, G. B., Henry, G. C., Macaya, C., O'Neill, B. J., Pucillo, A. L. Carere, R. G. et al. (1996) Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND study. Circulation, 94, pp. 258-265.
15. Matsushima, Y., Takase, B., Uehata, A., Kawano, H., Yano, K., Ohsuzu, F., Ishihara, M. and Kurita, A. (2007) Comparative predictive and diagnostic value of flow-mediated vasodilation in the brachial artery and intima media thickness of the carotid artery for assessment of coronary artery disease severity. International Journal of Cardiology, 25:117, pp. 165-172.
16. Panza, J. A., Quyyumi, A. A., Brush Jr., J. E. and Epstein, S. (1990) Abnormal endothelium dependent vascular relaxion, in patients with essential hypertension. New England Journal of Medicine, 323, pp. 22-27.
17. Parenti, A., Filippi, S., Amerini, S., Granger, H. J., Fazzini, A. and Ledda, F. (2000) Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol. Journal of Pharmacology and Experimental Therapeutics, 292, p. 698.
18. Schiffrin, E. L. and Deng, L. V. (1995) Comparison of effects of angiatensin I-converting enzyme inhibition and beta-blockade for 2 years on function of smail arteries from hypertensive patients. Hypertension, 25, pp. 699-703.
19. Sorensen, K. E., Dorup, I. and Celermajer, D. S. (1997) Noninvasive assessment of endothelial vasomotor funksiyon. Vascular Endothelium: Physiology, Pathology, and Therapeutic Opportunities, pp. 373-382. Schattauer, New York
20. Staub, D., Meyerhans, A., Bundi, B., Schmid, H. P. and Frauchiger, B. (2006) Prediction of cardiovascular morbidity and motality: comparasionof the internal carotid artery resistive index with the common carotid artery intima-media thickness. Stroke, 37, pp. 800-805.
21. Taddei, S., Virdis, A., Ghiadoni, L., Magagna, A., Pasini, A. F., Garbin, U., Cominacini, L. and Salvetti, A. (2001) Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. Journal of Hypertension, 19, pp. 1379-1386.
22. Troost, R., Schwedhelm, E., Rojczyk, S., Tsikas, D. and Frolich, J. C. (2000) Nebivolol decreases systemic oxidative stress in healthy volunteers. British Journal of Clinical Pharmacology, 50, pp. 377-379.
23. Tzemos, N., Lim, O. P. and MacDonald, T. M. (2001) Nebivolol reverses endothelial dysfunction in essential hypertension: A randomized, double-blind, crossover study. Circulation, 104, pp. 511-514.